Live Breaking News & Updates on Francina Agosti

Stay updated with breaking news from Francina agosti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Receives $1.2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Receives $1.2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New South Wales , Francina Agosti , Brianm Strem , California Newsfile Corp , Kiora Pharmaceuticals Inc , Kiora Pharmaceuticals , Retinitis Pigmentosa , Ocular Presentation , Rheumatoid Arthritis , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report ,

Kiora Pharmaceuticals Receives $1.2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease

Kiora Pharmaceuticals Receives $1.2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New South Wales , Brianm Strem , Francina Agosti , Kiora Pharmaceuticals , Kiora Pharmaceuticals Inc , California Newsfile Corp , Retinitis Pigmentosa , Ocular Presentation , Rheumatoid Arthritis , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report ,

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Announces Closing of $6.3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Encinitas, California (Newsfile Corp. - June 6, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the closing of an underwritten public offering for gross ....

Mecklenburg Vorpommern , United States , New York , Francina Agosti , Stefan Klotter , Kiora Pharmaceuticals Inc , Kiora Pharmaceuticals , Exchange Commission , California Newsfile Corp , Prospectus Department , Ladenburg Thalmann Co , Seriesf Convertible Preferred Stock , Classc Warrant , Classd Warrant , Classc Warrants , Classd Warrants , United States Securities , Ladenburg Thalmann , Ocular Presentation , Rheumatoid Arthritis , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report , Stabile Ertr , Chart Profi Stefan Klotter , Blue Chips ,

Kiora Pharmaceuticals Announces Closing of $6.3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Kiora Pharmaceuticals Announces Closing of $6.3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Francina Agosti , Kiora Pharmaceuticals , Kiora Pharmaceuticals Inc , Ladenburg Thalmann Co , Exchange Commission , California Newsfile Corp , Prospectus Department , Wall Street , Seriesf Convertible Preferred Stock , Classc Warrant , Classd Warrant , Classc Warrants , Classd Warrants , United States Securities , Ladenburg Thalmann , Ocular Presentation , Rheumatoid Arthritis , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report ,

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering

Encinitas, California (Newsfile Corp. - June 2, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the pricing of an underwritten public offering for gross ....

New York , United States , Francina Agosti , Exchange Commission , Prospectus Department , Ladenburg Thalmann Co , Kiora Pharmaceuticals Inc , California Newsfile Corp , Kiora Pharmaceuticals , Seriesf Convertible Preferred Stock , Classc Warrant , Classd Warrant , Classc Warrants , Classd Warrants , United States Securities , Ladenburg Thalmann , Ocular Presentation , Rheumatoid Arthritis , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report ,